Bismuth subsalicylate, metronidazole, and tetracycline and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Bismuth subsalicylate, metronidazole, and tetracycline and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bismuth subsalicylate / metronidazole / tetracycline
Brand name:
Synonyms: Bismuth subsalicylate, metronidazole, and tetracycline (Oral)
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bismuth subsalicylate, metronidazole, and tetracycline-Insulin glargine, recombinant Subcutaneous
- Bismuth subsalicylate, metronidazole, and tetracycline-Insulin glulisine
- Bismuth subsalicylate, metronidazole, and tetracycline-Insulin Glulisine (Cartridges and Pens)
- Bismuth subsalicylate, metronidazole, and tetracycline-Insulin Glulisine (Vials)
- Bismuth subsalicylate, metronidazole, and tetracycline-Insulin glulisine Subcutaneous
- Bismuth subsalicylate, metronidazole, and tetracycline-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Bisoprolol
- Insulin glargine and lixisenatide Subcutaneous-Bisoprolol and Hydrochlorothiazide
- Insulin glargine and lixisenatide Subcutaneous-Bisoprolol Fumarate
- Insulin glargine and lixisenatide Subcutaneous-Bite-A-Mins
- Insulin glargine and lixisenatide Subcutaneous-Bivalirudin
- Insulin glargine and lixisenatide Subcutaneous-Bivalirudin Intravenous